Akari Therapeutics plc ADS (NASDAQ: AKTX) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT AKARI THERAPEUTICS PLC ADS

Akari Therapeutics plc ADS (NASDAQ: AKTX)
Listen to this Section


$10.27
+0.7490 ( +7.87% ) 68.0K

Akari Therapeutics PLC is a clinical stage biopharmaceutical company. It is focused on developing therapies for autoimmune and inflammatory diseases involving the complement component 5 (C5) and leukotriene B4 (LTB4) pathways. The company's pipelines include HSCT-TMA and Geographic Atrophy (GA).

Clinical Trial Pipeline Stages


Drug Name Stage
NomacopanDetailsParoxysmal nocturnal hemoglobinuria Phase 3
NomacopanDetailsHematopoietic stem cell transplantation thrombotic microangiopathies Phase 3
NomacopanDetailsCOVID-19 Phase 2
NomacopanDetailsAtopic Keratoconjunctivitis Phase 1/2
NomacopanDetailsGeographic atrophy, Eye disease Phase 1
NomacopanDetailsBullous pemphigoid Failed

Market Data


Open $10.27
Previous Close $9.52
Volume 68.0K
Market Cap $16.93M
Day Range $9.37 - $12.06
52 Week Range $3.02 - $49.60
Shares Outstanding 1.57M
Change % +7.87%
Net Change ▲ 0.7490
Insider Ownership N/A
Exchange NASDAQ
SectorHealthcare
IndustryBiotechnology: Pharmaceutical Preparations
IPO Year2012
CountryUnited Kingdom

Insider Ownership Transactions

Total Amount Purchased: -3,404,356,151.00

Date Type Amount Purchased Purchaser
2026-03-16 Buy 2473.00 Neal James R
2025-12-18 Buy 247462.00 Patel Sandip I
2025-12-18 Buy 309328.00 Gaslightwala Abizer
2025-12-18 Buy 123731.00 Bazemore Robert B
2025-12-18 Buy 618658.00 Huh Hoyoung
2025-12-18 Buy 618658.00 Prudo-Chlebosz Raymond
2025-12-18 Buy 618658.00 Patel Samir Rashmikant
2025-12-18 Buy 24745.00 Farag Kameel D.
2025-08-29 Buy 10000.00 Gaslightwala Abizer
2025-06-25 Buy 943.00 Gaslightwala Abizer

SEC Filings


Form Type Description Pages Date
8-k 8K-related 39 Dec 08, 2025
424b3 Other 2 Dec 05, 2025
8-k 8K-related 13 Nov 26, 2025
s-1 Registration statements 17 Nov 17, 2025
def Proxies and info statements 4 Nov 17, 2025
10-q Quarterly Reports 83 Nov 13, 2025
pre Proxies and info statements 4 Nov 07, 2025
4 Insider transactions 1 Nov 04, 2025
4 Insider transactions 1 Oct 24, 2025
3 Insider transactions 2 Oct 24, 2025

Latest News